Shenzhen Macrolux Medical Technology Co., Ltd. (hereinafter referred to as Macrolux) recently announced the completion of its Series A round … More
Tag: Legend Capital
Innovation is the Key Benchmark, Focus on Four Healthcare Industry Sub-Sectors in 2023, Says Jafar Wang of Legend Capital
Legend Capital invested in 29 healthcare companies that officially disclosed financing rounds in 2022, according to the VBDATA Database. Since … More
Led by Legend Capital, GS Biotech Completes Nearly CNY100 million Pre-A Round Financing
Recently, Zhongke Guosheng (Hangzhou) Technology Co., Ltd (hereinafter referred to as GS Biotech) officially announced the completion of its nearly … More
Led by Legend Capital, PureFDA Secures Over CNY100 million in the Series B Round
Recently, PureFDA Medical Technology (Guangzhou) Co., LTD. (hereinafter referred to as PureFDA) announced the completion of the Series B round … More
Legend Capital Portfolio Company Giant Biogene Successfully Lists on the HKEX
On November 4, 2022, Legend Capital portfolio company Giant Biogene (HKG: 2367) was successfully listed on the main board of … More
Led by Legend Capital, ClinBrain Completes Nearly CNY200 million Series C Round
Recently, the healthcare big data leader ClinBrain completed the Series C round of financing of nearly CNY200 million, led by … More
Led by Legend Capital, Easy-Flow Raises Tens of Millions of CNY in Angel Round
Shanghai Easy-Flow (Easy-Flow) recently completed its Angel financing round by raising tens of millions of CNY, led by Legend Capital. … More
Co-Led by Legend Capital, Top Gene Delivery Enterprise VectorBuilder Secures CNY410mn in Series C Round
VectorBuilder Biotechnology (Guangzhou) Co., Ltd. (hereinafter referred to as VectorBuilder), a top gene delivery enterprise, recently announced the completion of … More
Legend Capital: The Logic of Technology Investment Has Changed
Legend Capital recently announced that it made its 100th IPO following the listing of its AI medical portfolio company Lunit … More
Led by Legend Capital, Multi-omics-leading Enterprise APTBIO Closes Series B with Hundreds of Millions of CNY
Shanghai Applied Protein Technology Co., Ltd. (APTBIO), a leading enterprise focused on mass spectrometry-based multi-omics applied to precision medicine, recently … More
SciTech World News 